BioTissue Ocular
Share
We develop innovative Amniotic Membrane products for the management of ocular surface diseases.
You asked the universe for a ringless CAM…
Data has shown CAM360 AmnioGraft™ promoted improvements in both signs and symptoms within 1-week in patients with mild to moderate DED.¹
Stevanovic, M, Ciarmiello, G, Eden, R, et al. Therapeutic Outcomes of Shelf-Stable, Cryopreserved Amniotic Membrane in Recalcitrant Keratopathy. Clin Ophthalmol. 2025;19:4545-4550. https://brnw.ch/21x2Hmm
05/14/2026
PECAA + BioTissue = better together 🤝
We’re heading to San Diego next week and bringing our team with us. Look out for these faces, we are here to help you make the most of your PECAA partnership.
Click here to claim your Sponsored Listing.
Category
Address
7300 Corporate Center Drive, Suite 700
Miami, FL
33126
